Youve already come so far, and were here to wrap you in support as you maintain weight loss after GLP-1
Administered by one of our qualified injectors, B12 vitamin is given intramuscular into either upper arm
Checking the Eligibility Boxes Not everyone is a candidate for semaglutide
Clinical Trials - Key findings Type 2 diabetes (40 weeks): HbA1c 1.241.48% (vs 0.41% placebo) Weight loss 4.57.6% (vs 1.7% placebo) Obesity without diabetes (72 weeks): Mean weight loss 11.2% 54.6% achieved 10% weight loss Improved cardiometabolic markers Efficacy similar to semaglutide/liraglutide (slightly less than tirzepatide) Safety: GI effects most common (during dose escalation) Low discontinuation rates No major hypoglycemia, hepatic, or CV safety signals so far Orforglipron combines oral convenience + GLP-1level efficacy, with the potential to improve access, adherence, and long-term outcomes in diabetes and obesity management
Safe and Effective Use of Tirzepatide Using tirzepatide involves straightforward, once-weekly injections administered at consistent times each week
Unlike oral supplements (2040% absorption), IV therapy ensures 90100% absorption, allowing your body to use nutrients immediately
:format(webp))
